000 04101cam a2200409 i 4500
001 1246352787
003 OSt
005 20231113131601.0
008 210417t20222022mdu b 001 0 eng c
010 _a2021007377
020 _a9781585287000
_q(paperback)
035 _a.b107322560
035 _a(OCoLC)1246352787
040 _aYDX
_beng
_erda
_cYDX
_dVRC
_dUAB
_dOCLCF
_dUtOrBLW
042 _apcc
049 _aOS2A
050 4 _aRM301.5
_bC587 2022
100 _aMurphy, John E.,
_d1945-
_eeditor.
245 0 0 _aClinical pharmacokinetics /
250 _a7th edition
264 1 _aBethesda, MD :
_bAmerican Society of Health-System Pharmacists,
_c[2022]
264 4 _c©2022
300 _axxiv, 552 pages ;
_c26 cm +
_e1 workbook (116 pages ; 28 cm)
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
504 _aIncludes bibliographical references and index
505 0 0 _gSection 1.
_tBasic concepts and special populations
_gChapter 1
_tRational use of drug concentration measurements /
_rJohn E. Murphy --
_gChapter 2.
_tAssessment of kidney function /
_rJoanna Q. Hudson --
_gChapter 3.
_tRenal drug dosing concepts /
_rDean A. Van Loo and Thomas C. Dowling --
_gChapter 4.
_tMedication dosing in overweight and obese patients /
_rBrian L. Erstad --
_gChapter 5.
_tPharmacogenomic impacts on pharmacokinetics /
_rCheryl D. Cropp -- Chapter 6.
_tDrug dosing in pediatric patients /
_rVinita B. Pai and Milap C. Nataha --
_gChapter 7.
_tConsiderations for medication use in the geriatric patient /
_rSusan W. Miller --
_gSection 2.
_tSpecific drugs and drug classes
_gChapter 8.
_tAminoglycosides /
_rKathryn R. Matthias and John E. Murphy. --
_gChapter 9.
_tAntidepressants /
_rPatrick R. Finley. --
_gChapter10.
_tAntiepileptics /
_rJacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin.
_gChapter 11.
_tAntirejection agents /
_rTony K.L. Kiang
_gChapter 12.
_tCarbamazepine /
_rJacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin --
_gChapter 13.
_tDigoxin /
_rRobert J. DiDomenico and Robert L. Page II --
_gChapter 14.
_tEthosuximide /
_rJacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin --
_gChapter 15.
_tUnfractioned Heparin, low-molecular-weight heparins, and Fondaparinux /
_rA. Joshua Roberts, Hahyoon Kim, and William E. Dager --
_gChapter 16.
_tLidocaine /
_rToby C. Trujillo --
_gChapter 17.
_tLithium /
_rTanya J. Fabian and Matthew A. Fuller --
_gChapter 18.
_tPhenobarbital /
_rKimberly B. Tallian and Douglas M. Anderson. --
_gChapter 19.
_tPhenytoin and Fosphenytoin /
_rWendy Chang and Tony K.L. Kiang --
_gChapter 20.
_tTheophylline /
_rCatherine B. Hobart and Hanna Phan --
_gChapter21.
_tValproate /
_rBarry E Gidal --
_gChapter 22.
_tVancomycin /
_rJeremiah J. Duby, Monica A. Donnelley, Chelsea L. Tasaka, and Brett H. Heinz --
_gChapter 23.
_tWarfarin /
_rSara R. Vazquez --
_gAppendix A.
_tTherapeutic ranges of drugs in traditional and SI units --
_gAppendix B.
_tNondrug reference ranges from common laboratory tests in traditional and SI units
520 _a"Written in a straightforward style, with numerous charts and lists, this reference + workbook makes complicated dosing and monitoring information easy to find and understand. Whether you are a student or practitioner, it is a resource you will turn to for reliable guidance throughout your pharmacy career...Clinical Pharmacokinetics, 7th Edition, includes the most current information, covering issues such as rational use of drug concentration measurements, changes in dosing obese patients, and considerations for a wider variety of drugs for special populations" -- Publisher's website
650 0 _aPharmacokinetics.
_0http://id.loc.gov/authorities/subjects/sh85100597
650 0 _aPharmacokinetics
_vHandbooks, manuals, etc
650 1 2 _aPharmacokinetics.
_0https://id.nlm.nih.gov/mesh/D010599
655 2 _aHandbook
655 7 _aHandbooks and manuals.
_2fast
_0(OCoLC)fst01423877
710 2 _aAmerican Society of Health-System Pharmacists.
_0http://id.loc.gov/authorities/names/no95010636
942 _2lcc
_cBK
999 _c2780
_d2780